Client News

InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update

DEBRA Research Collaborates with Queen Mary University of London to Advance Drug Development for Epidermolysis bullosa

InflaRx to Report Second Quarter 2025 Results on August 7, 2025

PL BioScience Announces Major Site Expansion

CorTec Announces Neurotech Milestone: First Human Implantation of a Brain-Computer Interface made in Germany

Meliodays and Celanese Partner for Meliodays’ Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain

Abivax Announces Closing of $747.5 Million Public Offering

Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

100 Patients Already Enrolled: ARTCLINE Reports Rapid Progress in Multicenter Clinical Study on Immune Support in Septic Shock (ReActIF-ICE)

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)